enVVeno Medical Files Prospectus To Offer And Sell Securities For Up To $100M
-SEC Filing
Stocks · News reference
EnVVeno Medical Issued U.S. Patent For Its Intellectual Property Portfolio Supporting Its enVVe Transcatheter Replacement Venous Valve System To Treat Venous Disease
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
enVVeno Announces Publication Of Peer-Reviewed Health Economics Study Supporting Venous Valve Therapy; Findings May Support Future Coverage And Reimbursement Decisions
Published economic health study shows both short- and long-term cost-effectiveness of replacement venous value therapy versus standard-of-care treatments for deep venous CVI, generating compelling evidence that will be
enVVeno Medical Says Peer-Reviewed Study Projects More Than $32K In Healthcare Savings Per Patient Over Five Years From Venous Valve Replacement Therapy
enVVeno Medical Q2 EPS $(5.37) Up From $(11.55) YoY